Shinar Y, Kuchuk I, Menasherow S, Kolet M, Lidar M, Langevitz P, Livneh A
Heller Institute, Sheba Medical Center, Tel Hashomer 52621, Israel.
Rheumatology (Oxford). 2007 Nov;46(11):1718-22. doi: 10.1093/rheumatology/kem228. Epub 2007 Oct 15.
To determine the spectrum of mutations in the Mediterranean fever gene (MEFV) of Iranian Jews with familial Mediterranean fever (FMF) and to analyse their clinical manifestations.
FMF patients with both parents of Iranian-Jewish (IJ) extraction or with one IJ parent (IJ-other, 10 of each) were characterized for clinical manifestations, and the B30.2 (PRYSPRY) domain of their MEFV was sequenced for mutations.
Only one rare mutation, R653H, and one new mutation, G632S were present in the IJ group (in 2/10 patients), whereas the new, and common mutations were present in the IJ-other patients (8/10 patients). The new mutation was traced thrice to an IJ ancestor, and although carried asymptomatically by family members, it was over-represented in the patients (3/28 unrelated IJ alleles) compared non-affected IJ subjects (1/126 alleles, P = 0.03) or with non-Jewish Iranians (0/108 alleles, P = 0.001). The mutation was associated with a distinct phenotype regarding sites involved in the attack (P = 0.001), mild severity, sole expression of febrile episodes (P = 0.01) and a male bias (P = 0.01). In two 3D PRYSPRY models the G632S mutation was localized to a surface loop and close to a putative binding site.
Iranian Jews with FMF have a unique spectrum of mutations including a newly described mutation with a non-typical phenotype.
确定患有家族性地中海热(FMF)的伊朗犹太人地中海热基因(MEFV)的突变谱,并分析其临床表现。
对父母均为伊朗犹太人(IJ)或父母一方为IJ(IJ-其他,各10例)的FMF患者进行临床表现特征分析,并对其MEFV的B30.2(PRYSPRY)结构域进行测序以检测突变。
IJ组中仅存在一种罕见突变R653H和一种新突变G632S(2/10例患者),而新的和常见突变存在于IJ-其他患者中(8/10例患者)。该新突变可追溯到一位IJ祖先三代,尽管家族成员无症状携带,但与未受影响的IJ受试者(1/126个等位基因,P = 0.03)或非犹太伊朗人(0/108个等位基因,P = 0.001)相比,在患者中其出现频率过高(3/28个无关IJ等位基因)。该突变与发作累及部位的独特表型相关(P = 0.001)、严重程度较轻、仅表现为发热发作(P = 0.01)以及男性偏多(P = 0.01)。在两个3D PRYSPRY模型中,G632S突变位于表面环且靠近一个假定的结合位点。
患有FMF的伊朗犹太人具有独特的突变谱,包括一种新描述的具有非典型表型的突变。